Although crypto markets seem like on a protracted, arduous path forward based mostly on current weeks of token turmoil, enterprise buyers trying to get their fingers on a Web3 future aren’t slowing down.

On Wednesday, enterprise capital big, A16Z, announced closing its fourth cryptocurrency fund at $4.5 billion. This brings the entire cash invested by Andreessen Horowitz in digital forex and blockchain enterprise to greater than $7.6 billion.

The brand new funding automobile will deal with early-stage concepts in addition to initiatives which might be extra mature and have already proven some traction. In accordance with the agency, $1.5 billion of the funding might be used for seed injections, whereas $3 billion might be devoted to enterprise investments.

Regardless of the present market downtown, the agency is optimistic about discovering recent prospects. Marc Andreessen, the co-founder of A16Z, commented that cryptocurrencies are nonetheless of their “early innings,” including that the market has plenty of progress potential.

The fourth crypto fund has been within the works for a while; Cointelegraph first reported on it in January. It doubles the scale of the earlier crypto fund and demonstrates the rising curiosity among the many agency’s restricted companions in boosting their publicity to cryptocurrency corporations.

The brand new funding has come lower than a 12 months since Andreessen Horowitz introduced the launch of its $2.2 billion Crypto Fund III. A16z’s dominance has made waves within the crypto trade all through current months, with a number of crypto native companies like Paradigm and Electric Capital raising enormous sums to compete in opposition to it.

Associated: $3B flows to metaverse and Web3 gaming this month as a16z tips in $600M

Previously recognized for investments in Instagram and Slack, the agency first entered the crypto sector with an funding in Coinbase in 2013. It has since backed quite a few crypto companies, together with Polychain Capital, OpenSea, Solana (SOL), Avalanche (AVAX) and Yuga Labs.